Strut Health offers compounded NAD+ injections through an online consultation and home-delivery service. Its dedicated NAD+ page presents a $149 auto-refill offer for a 500 mg vial. That makes it a useful comparison for readers who want to understand an ongoing medication subscription before committing to one.
This review examines Strut’s public offer, refund policy, and relevant FDA correspondence checked September 19, 2026. We have not ordered its medication or tested its service. The advertised benefits and quality statements remain provider claims; the practical question is what the actual prescription, support, and recurring payment would look like for you.
The published subscription is fairly specific about its starting vial and included services. Confirm the route, dispensing pharmacy, renewal cutoff, and current terms before ordering.
What the advertised $149 includes
The official NAD+ offer lists one 500 mg vial at $149 per month, with physician consultations and shipping included. It also advertises follow-ups and access to provider messaging. The page labels the offer as auto-refill; treat that as a recurring purchase rather than assuming it is a one-time order.
Ask for the exact amount due now and on the next billing date. A vial’s total ingredient amount does not establish the dose you should use or how long it will last under your prescription. The NAD+ cost guide explains why a monthly offer and a price per vial are not automatically interchangeable.
Make the route and formulation unambiguous
Strut’s dedicated NAD+ FAQ mentions both subcutaneous and intramuscular administration, while its other NAD+ safety page describes subcutaneous use. Those public descriptions should not become competing instructions at home. Ask the clinician and pharmacist to identify the route on the prescription and demonstrate the equipment that accompanies it.
The page also refers to more than one vial size. Request the concentration, total volume, supplied quantity, and pharmacy identity for the option selected for you. Our label-reading guide helps you organize those questions without trying to calculate a regimen from website copy.
Understand the refund cutoff before the refill
Strut’s refund policy says cancellation requests received after pharmacy processing cannot be refunded. It also says medication that has left the pharmacy cannot be returned for a refund. The policy directs customers with defective or damaged items to contact the company within two weeks of delivery.
The practical implication is that canceling an account and reversing an order are different requests. Get the processing deadline for your next refill, the cancellation method, and written confirmation when a change is made. Ask how the service handles a clinician stopping treatment after an order has begun processing; do not assume a general cancel-anytime statement answers that situation.
A regulatory record that belongs in the review
The FDA letter dated February 20, 2026 raised concerns about Strut’s marketing of compounded semaglutide and tirzepatide, including representations about who compounded the products and implications of FDA approval. It concerned those weight-loss products, not an NAD+ recall or a finding about your particular NAD+ vial.
For a prospective NAD+ customer, the useful follow-up is to ask who actually compounds the prescription and what documentation supports the current offer. We have not established the present resolution of that correspondence. Read the dated agency document in context rather than treating it as either a blanket verdict on every product or something a review should omit.
Read the benefit claims separately from the service offer
Convenient consultations and an included shipment are service features. They do not establish that a particular injection improves memory, energy, recovery, or lifespan. Strut’s page acknowledges that compounded NAD+ is not FDA-approved. Our evidence review explains why research on NAD biology and other delivery routes does not settle those outcomes.
If you are investigating persistent tiredness or a change in concentration, describe the symptom before choosing the product. Ask what other explanations deserve assessment and how the clinician would decide whether continuing treatment makes sense. A planned refill should not substitute for a discussion of whether the treatment is helping.
Questions for the care team
Before payment, ask which clinician will evaluate you in your state and how to reach clinical support after delivery. If you prefer a telephone conversation, ask whether that is available and included. Written messaging may be convenient, but its usefulness depends on response times and whether the person responding can address a medication concern.
Have the pharmacy explain storage, the beyond-use date, and what to do with a delayed or damaged parcel. A website promise about quality does not replace directions for the dispensed preparation. Keep the consultation checklist beside the order summary so billing and care questions receive separate answers.
Where Strut fits in a provider comparison
Strut is worth comparing with other clinician-reviewed home injection subscriptions if that delivery model fits your needs. Read our AgelessRx review for a different billing structure and Drip Hydration review for the distinction between a mailed kit and a nurse visit.
Our CoreAge Rx review covers the site’s featured commercial partner, including its own pricing discrepancy. Comparing those concrete terms is more useful than choosing whichever page makes the strongest longevity promise. You can also use the local directory when an in-person assessment would better address your concern.
Follow the source
References & further reading
- Strut Health — NAD+ injection subscription
Provider offer, checked September 19, 2026. Auto-refill price and included services are advertising, not a completed order.
- Strut Health — NAD+ product and safety information
A second provider page. Its subcutaneous route wording differs from the dedicated offer FAQ; obtain prescription-specific directions.
- Strut Health — refund policy
Published policy checked September 19, 2026; the page carries a September 2021 modification date. Pharmacy processing affects cancellation refunds.
- FDA — Strut Health warning letter, February 20, 2026
Concerns compounded semaglutide and tirzepatide advertising, not an NAD+ recall. Current resolution was not established by this review.
- FDA — compounding questions and answers
Compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality.
- FDA — ingredients suitable for sterile compounding
Reports NAD+ injectable adverse events and ingredient-quality concerns.
- HHS — licensing across state lines
Licensing pathways vary by state and profession; confirm your clinician can treat you where you are located.